Tag: patent cliff
-
Expanding pharmaceutical local production in Africa: An idea whose time has come?
There is a groundswell in Africa in support of local pharmaceutical production. Africa’s dependency on the rest of the world…
-
What does China’s open policy mean to pharma multinationals?
Multinationals (MNCs) were thrilled by China’s recent policies on opening up the domestic pharmaceutical market to the world. <ClickHere>
-
Key Business Strategy Tools to Survive a Patent Cliff in the Biopharmaceutical Industry
This case study presents the research gathered in seeking to identify a number of key business strategy tools that biopharmaceutical…
-
Surviving patent expiration: strategies for marketing pharmaceutical products
The pharmaceutical industry is characterized by high R&D costs and increasing competition. New pharmaceutical products are often provided patent protection…
-
NHS England to save £300m after patent expiry of most costly drug
By replacing adalimumab with biosimilar versions, NHS hospitals will only pay a quarter of the £400m they currently spend each year on…
-
The key covid-19 compulsory licensing developments so far
Governments are beginning to adopt extraordinary measures to tackle the covid-19 pandemic. Given the seriousness of the current health crisis,…
-
Coronavirus Patents: China Files for Remdesivir Patent, but Gilead Sciences Will Still Come Out a Winner
On February 4, the Wuhan Institute of Virology announced that it had applied for a Chinese patent on Gilead’s Remdesivir…
-
Medical supply chains are fragile in the best of times and COVID-19 will test their strength
The COVID-19 pandemic has brought medical supply chains into the spotlight. <ClickHere>
-
Will governments override patent rights in the race to find a cure for COVID-19?
The outbreak of COVID-19 coronavirus has prompted a global race to find a vaccine to fight the disease. <ClickHere>
-
“Playing Both Sides?” Branded Sales, Generic Sales and Patent Policy
In this article, we explore a phenomenon we call “playing both sides”: companies that participate in pharmaceutical markets as both…